# A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers

> **NCT00000808** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 49 (—)

## Conditions studied

- HIV Infections
- Pregnancy

## Interventions

- **DRUG:** Nevirapine

## Key facts

- **NCT ID:** NCT00000808
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1998-09
- **Target enrollment:** 49 (—)
- **Last updated:** 2021-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000808, "A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00000808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*